BPC 157 entered early-phase clinical development for inflammatory bowel disease as PL 14736 (Pliva, Croatia), and a 2025 pilot examined intravenous administration in a small cohort, but no adequately powered randomised controlled trial exists
Keeping it stable is straightforward if you follow a few basics: As a powder: store frozen (around 20C), away from light and moisture, for long-term stability
Worth Noting BPC-157 has one of the broadest research profiles of any peptide available
Musculoskeletal Causes (Including Costochondritis) Musculoskeletal pain is one of the most common noncardiac sources of chest discomfort
Independent testing has found that many so-called BPC-157 products do not actually contain the compound, or contain it in impure forms that could be contaminated with other substances
For Ozempic users adding peptides, the quality consideration becomes particularly important